SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-20-002837
Filing Date
2020-02-07
Accepted
2020-02-07 06:09:23
Documents
3
Period of Report
2020-02-07

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER f6k020720_alteritytherap.htm 6-K 13479
2 NASDAQ NON-COMPLIANCE NOTICE RECEIVED f6k020720ex99-1_alterity.htm EX-99.1 13912
3 GRAPHIC ex99-1_001.jpg GRAPHIC 13739
  Complete submission text file 0001213900-20-002837.txt   47552
Mailing Address LEVEL 3, 460 BOURKE STREET MELBOURNE C3 VIC 3000
Business Address LEVEL 3, 460 BOURKE STREET MELBOURNE C3 VIC 3000 61 3 9349 4906
ALTERITY THERAPEUTICS LTD (Filer) CIK: 0001131343 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-49843 | Film No.: 20584458
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences